In addition to being a typical dihydropyridine substrate of CYP3A, AML inhibits other CYP enzymes such as CYP2C9 and CYP2C19, as demonstrated by the IC50 values presented in Table 3. The gene discussed is CYP3A4; the disease is acute myeloid leukemia.